企業プロフィール
ANI Pharmaceuticals 株価・ニュース・カタリスト
- ティッカー:
- ANIP
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
76.00 USD (-0.71%)
終値
最終更新: 2026年8月17日
1.7B USD
時価総額
株価変動の要因
As of Aug 17, 2026, ANIP closed down 0.71% at $76.00. No new same-company headline was identified in the current news window.
企業概要
Rare-Disease and Specialty Pharmaceuticals
ANI Pharmaceuticals develops and commercializes medicines across rare disease, ophthalmology and established pharmaceutical markets. Its model combines branded specialty products with a portfolio of generic medicines.
Cortrophin Gel
Purified Cortrophin Gel is an adrenocorticotropic hormone therapy used across selected autoimmune and inflammatory indications. It is the primary growth driver of ANI's rare-disease franchise.
Ophthalmology Portfolio
ILUVIEN and YUTIQ are sustained-release fluocinolone implants for retinal diseases, including diabetic macular edema and chronic noninfectious uveitis affecting the posterior segment.
今後のカタリスト
- Phase 4 SYNCHRONICITY results in noninfectious uveitis at a medical conference in the third quarter of 2026.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。